Genomic Valley

₹34 1.6 | 5%

WEBSITE BSE:539206 NSE : GVBL 18 May, 10:00

Market Cap ₹10 Cr.

Stock P/E 345.7

P/B 2.9

Current Price ₹34

Book Value ₹ 11.6

Face Value 10

52W High ₹50.1

Dividend Yield 0%

52W Low ₹ 20.7

Edit Ratio

Genomic Valley Research see more...

Overview Inc. Year: 1994Industry: Agriculture

Genomic Valley Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Genomic Valley Quarterly Results

#(Fig in Cr.)	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	0	1	0	1	1	0	0	0	0
Other Income	0	0	0	0	0	0	0	0	0
Total Income	0	1	0	1	1	0	0	0	0
Total Expenditure	0	1	0	1	0	0	0	0	0
Operating Profit	-0	-0	-0	0	1	0	0	0	-0
Interest	0	0	0	0	0	0	0	0	0
Depreciation	-0	0	0	0	-0	0	0	0	0
Exceptional Income / Expenses	0	1	0	-1	0	0	0	0	0
Profit Before Tax	0	0	0	-1	1	0	0	0	-0
Provision for Tax	0	0	0	0	0	0	0	0	0
Profit After Tax	0	0	0	-1	1	0	0	0	-0
Adjustments	0	0	0	0	0	0	-0	-0	-0
Profit After Adjustments	0	0	0	-1	1	0	0	0	-0
Adjusted Earnings Per Share	0.5	1.5	0.2	-2.8	3.2	0.1	0.1	0.1	-0.1

Genomic Valley Profit & Loss

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	0	0	0	1	1	1	0	0	3	0
Other Income	0	0	0	0	0	0	0	0	0	0
Total Income	0	0	1	1	1	1	0	0	3	0
Total Expenditure	0	1	1	0	1	0	0	0	2	0
Operating Profit	0	-0	-0	0	0	1	-0	-0	1	0
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	-0	0
Profit Before Tax	-0	-0	-0	0	0	0	-1	-0	1	0
Provision for Tax	-0	-0	-0	0	0	-0	0	0	0	0
Profit After Tax	-0	-0	-0	0	0	0	-1	-0	1	0
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	-0	-0	-0	0	0	0	-1	-0	1	0
Adjusted Earnings Per Share	-0	-1.1	-0.2	0.1	0.8	0.9	-1.8	-0	2.1	0.2

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	0%	44%	25%	0%
Operating Profit CAGR	0%	0%	0%	0%
PAT CAGR	0%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	56%	13%	NA%	NA%
ROE Average	20%	3%	4%	1%
ROCE Average	20%	5%	5%	2%

Genomic Valley Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	4	6	6	6	4	5	5	5	4	3	4
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	1	1	1	1	1	1	1	1	2	0	0
Other Non-Current Liabilities	0	0	-0	-0	-0	0	1	1	1	1	0
Total Current Liabilities	2	1	1	1	1	1	0	1	1	0	1
Total Liabilities	7	7	7	7	6	7	7	8	8	4	4
Fixed Assets	3	3	3	3	4	4	4	4	6	2	0
Other Non-Current Assets	0	0	1	3	2	2	3	3	2	1	2
Total Current Assets	3	3	3	0	0	0	0	0	0	1	3
Total Assets	7	7	7	7	6	7	7	8	8	4	4

Genomic Valley Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	1	1	0	0	0	0	0	0	0	0
Cash Flow from Operating Activities	1	0	0	-1	0	1	-1	0	1	-2	-1
Cash Flow from Investing Activities	-0	0	-1	1	-0	-1	0	-0	-2	4	2
Cash Flow from Financing Activities	0	0	0	0	0	0	1	0	0	-2	-1
Net Cash Inflow / Outflow	1	0	-1	-0	0	-0	0	-0	-0	-0	0
Closing Cash & Cash Equivalent	1	1	0	0	0	0	0	0	0	0	0

Genomic Valley Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	0	0	0	0	0	0	0	0.94	-1.83	-0.03	2.12
CEPS(Rs)	0.01	0.02	-0	-0.93	-0.08	0.36	1.4	1.52	-1.21	0.25	2.15
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	0	0	0	0	0	0	0	16.52	14.69	9.42	11.55
Core EBITDA Margin(%)	-11.57	13.1	-149.51	-406.62	-23.19	16.98	42.24	65.4	-65.57	-534.82	32.38
EBIT Margin(%)	12.49	23.09	63.1	-301.35	-15.63	9.92	24.08	45.97	-155.09	58.73	23.94
Pre Tax Margin(%)	12.37	6.06	-35.95	-316.31	-15.83	9.86	23.83	24.3	-241.16	-2.34	23.83
PAT Margin (%)	4.37	4.43	-27.76	-307.08	-15.54	5.73	23.6	33.78	-268.67	-13.24	23.81
Cash Profit Margin (%)	12.75	8.54	-0.77	-261.04	-5.82	18.47	43.27	54.88	-177.74	106.31	24.1
ROA(%)	0.02	0.05	-0.11	-4.61	-1.05	0.54	3.36	3.78	-7.19	-0.16	15.78
ROE(%)	0.03	0.09	-0.17	-7.08	-1.51	0.76	5.01	5.83	-11.73	-0.25	20.24
ROCE(%)	0.08	0.41	0.34	-5.99	-1.31	1.12	4.12	6.1	-5.14	0.93	20.35
Receivable days	0	0	0	0	0	14.27	15.14	34.74	146.98	0	297.29
Inventory Days	0	0	0	0	58.46	31.88	28.15	52.32	0	0	0
Payable days	0	0	0	0	18.69	70.53	44.49	-183.03	231.43	3716	70.37
PER(x)	0	0	0	0	0	0	0	0	0	0	0
Price/Book(x)	0	0	0	0	0	0	0	0	0	0	0
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	106.56	35.27	119.7	34.81	8.51	6.38	4.53	5.31	22.06	43.25	1.11
EV/Core EBITDA(x)	510.6	129.66	132.87	-13.63	-144.05	33.44	10.35	7.92	-34.38	-10.4	3.26
Net Sales Growth(%)	0	200.58	-65.16	259	304.76	34.71	65.7	-14.06	-75.42	-66.09	3758.23
EBIT Growth(%)	0	455.78	-4.81	-1814.64	79	185.52	301.97	64.09	-182.93	112.84	1472.77
PAT Growth(%)	0	204.52	-318.47	-3871.58	79.52	149.71	582	23.01	-295.48	98.33	7040.47
EPS Growth(%)	0	0	0	0	0	0	0	0	-295.48	98.33	7035.62
Debt/Equity(x)	0.23	0.15	0.15	0.16	0.17	0.17	0.31	0.29	0.34	0	0
Current Ratio(x)	1.47	5.39	3.46	0.32	0.26	0.06	4.14	0.53	0.19	5.31	2.89
Quick Ratio(x)	1.47	5.39	3.46	0.32	0.17	0.04	2.51	0.36	0.19	5.31	2.89
Interest Cover(x)	102.02	1.36	0.64	-20.15	-79.84	144.28	96.99	2.12	-1.8	0.96	225.3
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0	0	0

Genomic Valley Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	67.85	67.85	67.85	67.85	67.85	67.18	67.18	66.32	65.04	64.2
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	32.15	32.15	32.15	32.15	32.15	32.82	32.82	33.68	34.96	35.8
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.21	0.21	0.21	0.21	0.21	0.21	0.21	0.2	0.2	0.2
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.11	0.11
Others	0	0	0	0	0	0	0	0	0	0
Total	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31

Pros

Debtor days have improved from 3716 to 70.37days.
Company is almost debt free.

Cons

Company has a low return on equity of 3% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Genomic Valley News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 3400/-

Indian Potash

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Genomic Valley

Add Watchlist

Genomic Valley Research see more...

Overview Inc. Year: 1994Industry: Agriculture

Genomic Valley Share Price

Alert Data

Quarterly Price

Peer Comparison

Genomic Valley Quarterly Results

Genomic Valley Profit & Loss

Growth Rates

Genomic Valley Balance Sheet

Genomic Valley Cash Flow

Genomic Valley Ratios

Genomic Valley Shareholding Pattern

Genomic Valley News

Top Unlisted Companies & InstaBuy Companies

Indian Potash

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!